Search
for
Sort by
Research 31–60 of 1000+
- Safety of low‐dose oral minoxidil treatment for hair loss. A systematic review and pooled‐analysis of individual patient data
- Safety and Effectiveness of Juvéderm Ultra Plus Injectable Gel in Correcting Severe Nasolabial Folds in Chinese Subjects
- Safety and Efficacy of Adalimumab for the Treatment of Severe Alopecia Areata: Case Series of Three Patients
- Safety Considerations and Monitoring in Patients Treated with Systemic Medications for Acne
- Safety of skin care products during pregnancy.
- Safety and Efficacy of Intravenous ExoFlo in the Treatment of Complex Regional Pain Syndrome
- Safety and Biocompatibility of Mupirocin Nanoparticle-Loaded Hydrogel on Burn Wound in Rat Model
- Safety Profile of Finasteride: Distribution of Adverse Effects According to Structural and Informational Dichotomies of the Mind/Brain
- Safety and Efficacy of Rice Bran Supercritical CO<sub>2</sub> Extract for Hair Growth in Androgenic Alopecia: A 16-Week Double-Blind Randomized Controlled Trial
- Safety of Common Medications for Treating Dermatology Disorders in Pregnant Women
- Safety and efficacy of transdermal testosterone for treatment of hypoactive sexual desire disorder
- Safety and efficacy of platelet-rich plasma injection for treatment of erectile dysfunction: a prospective randomized controlled study
- Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial
- Safety and tolerability of antiepileptic drugs in women with epilepsy (literature review and own data)
- Safety Evaluation of Topical Valproate Application
- Safety and Efficacy Assessment of Red Ginseng Oil (RXGIN) in Men with Lower Urinary Tract Symptoms in a Randomized, Double-Blind, Placebo-Controlled Trial
- Safety of Whole-Body Abrogation of the TRF1 Shelterin Protein in Wild-Type and Cancer-Prone Mouse Models
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment
- Safety and Efficacy of Ritlecitinib for the Treatment of Patients with Alopecia Areata: A Systematic Review and Meta-Analysis of Controlled Trials
- Safety and efficacy of oral administrated cepharanthine in non-hospitalized, asymptomatic or mild COVID-19 patients: a Double-blind, randomized, placebo-controlled trial
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Safety and efficacy of ALRV5XR in men with androgenetic alopecia: A randomised, double-blinded, placebo-controlled clinical trial
- Safety and efficacy of advanced and targeted acid α-glucosidase (AT-GAA) (ATB200/AT2221) in ERT-switch nonambulatory patients with Pompe disease: preliminary results from the ATB200-02 trial
- Safety measures in high-risk patients with cardiovascular disease and elderly patients undergoing hair restoration surgery
- Safety assessment of cyclin-dependent kinase 4/6 inhibitors and comparison of time to adverse events
- Safety and efficacy of hairy scalp donors in thick split-thickness skin grafting: Healing and complications at donor sites
- Safety and tolerability of low-dose oral minoxidil in adolescents: A retrospective review
- Safety and Efficacy of Mesotherapy in the Treatment of Androgenetic Alopecia: A Systematic Review
- Safety and efficacy of a topical treatment (SM04554) for androgenetic alopecia (AGA): Results from a phase 1 Trial